US 9072710
Injectable ibuprofen formulation
granted A61KA61K31/192A61K47/02
Quick answer
US patent 9072710 (Injectable ibuprofen formulation) held by Cumberland Pharmaceuticals Inc. expires Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Cumberland Pharmaceuticals Inc.
- Grant date
- Tue Jul 07 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 02 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 37
- CPC classes
- A61K, A61K31/192, A61K47/02, A61P, A61P29/00